Tiziana Life Sciences Ltd – NASDAQ:TLSA
Founder-led company
Tiziana Life Sciences Ltd stock price today
$1.77
+1.09
+163%
Financial Health
0
1
2
3
4
5
6
7
8
9
Market closed
Open in 3 days
Tiziana Life Sciences Ltd stock price monthly change
-16.71%
month
Tiziana Life Sciences Ltd stock price quarterly change
-16.71%
quarter
Tiziana Life Sciences Ltd stock price yearly change
+13.89%
year
Tiziana Life Sciences Ltd key metrics
Market Cap | 82.88M |
Enterprise value | 30.35M |
P/E | -26.92 |
EV/Sales | N/A |
EV/EBITDA | -15.54 |
Price/Sales | N/A |
Price/Book | 1.28 |
PEG ratio | N/A |
EPS | N/A |
Revenue | N/A |
EBITDA | N/A |
Income | N/A |
Revenue Q/Q | N/A |
Revenue Y/Y | N/A |
Profit margin | 0% |
Oper. margin | 0% |
Gross margin | 0% |
EBIT margin | 0% |
EBITDA margin | N/A |
Sign up &
create your own Smart Feed
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeTiziana Life Sciences Ltd stock price history
Tiziana Life Sciences Ltd stock forecast
Tiziana Life Sciences Ltd financial statements
| Dec 2020 | 0 | -21.43M | |
|---|---|---|---|
| Jun 2022 | 0 | -4.51M | |
| Dec 2022 | 0 | -10.88M | |
| Jun 2023 | 0 | 0 |
| 2025 | 0 | -47.91M |
|---|
Analysts Price target
Financials & Ratios estimates
| Dec 2022 | 26477000 | 6.90M | 26.08% |
|---|---|---|---|
| Apr 2023 | 0 | 0 | |
| Jun 2023 | 17418000 | 4.12M | 23.67% |
| Dec 2023 | 12184000 | 6.64M | 54.56% |
| Jun 2021 | -13.05M | -20.83K | -274.96K |
|---|---|---|---|
| Jun 2022 | -11.91M | -3.48M | 0 |
| Dec 2022 | -7.70M | -513K | -55K |
| Jun 2023 | 0 | 0 | 0 |
Tiziana Life Sciences Ltd alternative data
| Aug 2023 | 9 |
|---|---|
| Sep 2023 | 9 |
| Oct 2023 | 9 |
| Nov 2023 | 9 |
| Dec 2023 | 9 |
| Jan 2024 | 9 |
| Feb 2024 | 9 |
| Mar 2024 | 9 |
| Apr 2024 | 9 |
| May 2024 | 9 |
| Jun 2024 | 9 |
| Jul 2024 | 9 |
Tiziana Life Sciences Ltd other data
0.16%
-5.23%
of TLSA is owned by hedge funds
160.37K
-5.11M
shares is hold by hedge funds
| Insider | Compensation |
|---|---|
Mr. Gabriele Marco Antonio Cerrone M.B.A., MBA (1972) Founder & Executive Chairman | $13,760,000 |
Dr. Kunwar Shailubhai M.B.A., Ph.D. (1958) Chief Executive Officer, Chief Scientific Officer & Executive Director | $810,000 |
-
What's the price of Tiziana Life Sciences Ltd stock today?
One share of Tiziana Life Sciences Ltd stock can currently be purchased for approximately $1.77.
-
When is Tiziana Life Sciences Ltd's next earnings date?
Unfortunately, Tiziana Life Sciences Ltd's (TLSA) next earnings date is currently unknown.
-
Does Tiziana Life Sciences Ltd pay dividends?
No, Tiziana Life Sciences Ltd does not pay dividends.
-
How much money does Tiziana Life Sciences Ltd make?
Tiziana Life Sciences Ltd has a market capitalization of 82.88M.
-
What is Tiziana Life Sciences Ltd's stock symbol?
Tiziana Life Sciences Ltd is traded on the NASDAQ under the ticker symbol "TLSA".
-
What is Tiziana Life Sciences Ltd's primary industry?
Company operates in the Healthcare sector and Biotechnology industry.
-
How do i buy shares of Tiziana Life Sciences Ltd?
Shares of Tiziana Life Sciences Ltd can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are Tiziana Life Sciences Ltd's key executives?
Tiziana Life Sciences Ltd's management team includes the following people:
- Mr. Gabriele Marco Antonio Cerrone M.B.A., MBA Founder & Executive Chairman(age: 53, pay: $13,760,000)
- Dr. Kunwar Shailubhai M.B.A., Ph.D. Chief Executive Officer, Chief Scientific Officer & Executive Director(age: 67, pay: $810,000)
-
Is Tiziana Life Sciences Ltd founder-led company?
Yes, Tiziana Life Sciences Ltd is a company led by its founder Mr. Gabriele Marco Antonio Cerrone M.B.A., MBA.
-
How many employees does Tiziana Life Sciences Ltd have?
As Jul 2024, Tiziana Life Sciences Ltd employs 9 workers.
-
When Tiziana Life Sciences Ltd went public?
Tiziana Life Sciences Ltd is publicly traded company for more then 6 years since IPO on 20 Nov 2018.
-
What is Tiziana Life Sciences Ltd's official website?
The official website for Tiziana Life Sciences Ltd is tizianalifesciences.com.
-
How can i contact Tiziana Life Sciences Ltd?
Tiziana Life Sciences Ltd can be reached via phone at +44 20 7495 2379.
Tiziana Life Sciences Ltd company profile:
Tiziana Life Sciences Ltd
tizianalifesciences.comExchange:
NASDAQ
Full time employees:
9
Industry:
Biotechnology
Sector:
Healthcare
Tiziana Life Sciences Ltd, a biotechnology company, focuses on the discovery and development of molecules to treat human diseases in oncology and immunology. The company's lead product candidate in immunology is Foralumab (TZLS-401), a human anti-CD3 monoclonal antibody (mAb) for the treatment of Crohn's, graft versus host, ulcerative colitis, multiple sclerosis, type-1 diabetes, inflammatory bowel, psoriasis, and rheumatoid arthritis diseases. It also develops Milciclib (TZLS-201), a small molecule inhibitor of various cyclin-dependent kinases, tropomycin receptor kinases, and Src family kinases controlling cell growth and malignant progression of cancer; and anti-Interleukin 6 receptor (IL6R) mAb (TZLS-501), a fully human monoclonal antibody for the treatment of IL6-induced inflammation and to treat COVID-19 patients. The company was incorporated in 1998 and is headquatered in London, the United Kingdom.
55 Park Lane
London, W1K 1NA
London, W1K 1NA
CIK: 0001723069
ISIN: BMG889121031
CUSIP: 88875G101
